Background. Myonecrosis due to group A streptococci (GAS) often develops at sites of nonpenetrating muscle injury, and nonsteroidal anti-inflammatory drugs (NSAIDs) may increase the severity of these cryptic infections. We have previously shown that GAS bind to vimentin on injured skeletal muscles in vitro. The present study investigated whether vimentin up-regulation in injured muscles in vivo is associated with homing of circulating GAS to the injured site and whether NSAIDs facilitate this process.
The incidence of invasive infections with group A streptococci (GAS), such as necrotizing fasciitis, myonecrosis, and streptococcal toxic shock syndrome (StrepTSS), remains at 3.5 cases per 100,000 population per year [1] . Despite better clinical recognition of StrepTSS and intense research on streptococcal virulence factors, morbidity is high, and the mortality rate remains between 30% and 70% [1] .
Nearly half of all patients with StrepTSS who have necrotizing fasciitis or myonecrosis develop deep-seated infection at the site of minor, nonpenetrating trauma or muscle strain [2] [3] [4] . For instance, of the 20 patients with invasive streptococcal infection described by Stevens et al. [2] , 12 had a defined portal of entry. Of the remaining 8 patients, 1 had a superficial bruise to the hand, and the portal of entry was entirely unknown in the other 7 [2] . Thus, 8 (40%) of 20 patients in this series had no defined portal of entry, and the overall mortality rate was 30% [2] . Similarly, a report by Adams et al. [3] documented 21 cases of life-threatening GAS infection; 19 patients lacked an obvious portal of entry, and 18 (85.7%) died. Finally, a recent case-control study found that nonpenetrating trauma was significantly associated with GAS necrotizing fasciitis [4] . In these cryptic infections, the correct diagnosis is often delayed until after shock and organ failure are manifest [1] , often causing the mortality rate to exceed 70% [3] . Survivors undergo emergent amputation or extensive surgical debridement and prolonged hospitalization [1, 2, 5] .
After minor injury, nonsteroidal anti-inflammatory drugs (NSAIDs) are frequently self-prescribed or given in emergency departments to alleviate pain. Because NSAIDs dysregulate production of the cytokines that mediate septic shock, Stevens [6] proposed that NSAIDs may actually predispose individuals to more-severe streptococcal infection. Some clinical epidemiologic studies have confirmed the association between NSAIDs and streptococcal infection, yet controversy still exists (reviewed in [7] ).
Our initial analyses of the molecular mechanisms responsible for these cryptic necrotizing GAS infections demonstrated that injury of cultured human skeletal muscle cells increases the binding of GAS and that increased levels of surface-expressed vimentin correlates with enhanced adhesion [8] . In addition, we have shown that GAS bind to vimentin on the surface of skeletal muscle cells in vitro and that GAS are found in association with vimentin-positive necrotic muscle in vivo [8] .
To further investigate the role of vimentin in GAS infection at sites of muscle injury, the present study used a murine model of eccentric contraction (EC) [9, 10] to mimic the antecedent injury in the "no-portal" group of human GAS myonecrosis cases. Here, the anterior hind-limb muscles were electrically stimulated to contract while the foot was mechanically flexed in the opposite direction, thereby creating a muscle strain. At 48 h after EC-induced injury, when vimentin was maximally expressed, M type 3 GAS were delivered intravenously. In separate experiments, animals received a nonselective NSAID before GAS infusion. The homing of GAS to injured muscle was determined by comparing the number of bacteria in exercised and contralateral, nonexercised muscle homogenates. The results demonstrated that moderate injury is sufficient to initiate GAS infection and that NSAIDs greatly augment this process.
METHODS

EC exercise protocol.
Animal studies were approved by the Boise Veterans Affairs Medical Center's Subcommittee on the Use and Care of Animals in Research. Adult Swiss Webster mice (female; weight, 22-28 g; Charles River Laboratories) were anesthetized (2% isoflurane) and positioned on a temperaturecontrolled platform adjacent to a muscle physiology apparatus (modification of model 360B; Aurora Scientific) that permits measurement and control of both ankle dorsiflexion torque and muscle length (position) [9] . The tibialis anterior (TA) and extensor digitorum longus (EDL) muscles were stimulated electrically at a frequency of 100 -150 Hz by sterile 28-gauge needle electrodes placed subcutaneously 2-3 mm apart near the right peroneal nerve, just lateral to the midline and distal to the knee joint. The maximal mean isometric torque (MIT) generated by 2 isometric contractions (with the foot held stationary) was recorded for each animal before exercise. The peroneal nerve was stimulated 50 times for 600 ms at 30-s intervals, with the ankle plantar flexing 78°starting 200 ms after nerve stimulation (normal active tibiotarsal angle, ϳ50°-80°).
The opposite leg of each animal was not exercised and served as a control. A separate group of animals was similarly treated, except that the foot was held stationary (isometric contraction).
After completion of the exercise protocol, maximal MIT was again measured. After this, the electrodes were removed, and the animal was immediately treated with a single dose of the analgesic buprenorphine at 0.1 mg/kg in 0.5 mL sterile saline given subcutaneously in the scruff of the neck. The animal was allowed to recover from anesthesia and returned to its cage. EC is a wellcharacterized model for muscle injury that demonstrates (1) injury and repair-specific alterations in cytoskeletal architecture and (2) alterations in muscle-specific gene expression, including vimentin up-regulation [10] .
EC-induced vimentin gene expression. The TA muscles from both exercised and contralateral, nonexercised legs were harvested at 12, 24, 48, or 72 h after exercise and immediately flash-frozen in liquid nitrogen for subsequent analysis of vimentin expression by real-time reverse-transcriptase polymerase chain reaction (rtRT-PCR). A separate group of animals (n ϭ 4) underwent the isometric exercise, and their muscles were harvested at 48 h. Frozen muscles were treated for 16 -24 h with a commercial RNA stabilization reagent (RNAlater; Ambion) at Ϫ20°C and then ground using an RNase-free mortar and pestle (Kontes). The lysates were passed through a column-based tissue shredder (QIAshredders; Qiagen) to complete the cellular disruption. Total RNA was extracted and cleared of contaminating genomic DNA by means of a commercial kit (RNeasy Fibrous Tissue Mini Kit; Qiagen). RNA quantity and quality were assessed by absorption spectrometry and gel electrophoresis, respectively.
RNA (1 g) was reverse transcribed using the ReactionReady First Strand cDNA Synthesis Kit (SuperArray), in accordance with the manufacturer's instructions. RNA with no reverse transcriptase served as the negative control. The resultant cDNA or a vimentin-positive control plasmid (OriGene) was added to 96-well reaction plates (MicroAmp Fast Optical plates; Applied Biosystems) containing SYBR Green/ROX PCR Master Mix (SuperArray), along with primers for vimentin (Sigma; [10] ) or murine glyceraldehyde 3-phosphate dehydrogenase (GAPDH; SuperArray). rtRT-PCR was performed on an ABI 7500 Fast PCR machine (Applied Biosystems) with the following parameters: 95°C for 10 min, 40 cycles of 95°C for 15 s, and 60°C for 1 min. A dissociation (melting) curve was run immediately after the PCR program to verify product integrity.
The threshold cycle (C t ) for each transcript and the change in threshold cycle (⌬C t ) for the vimentin/GAPDH pair of transcripts were monitored for each amplification reaction using Applied Biosystems software (version 1.3.1), and the data were analyzed using the ⌬⌬C t values for the vimentin expression to calculate the fold change between the exercised and nonexercised muscles.
Streptococcus pyogenes strain. GAS strain 88-003 is an M type 3 GAS isolated from a fatal human case of StrepTSS with myonecrosis [2] . This strain has been characterized elsewhere [2] and has been submitted to the American Type Culture Col-lection (ATCC 51550). It has also been shown to bind to immobilized vimentin in vitro [8] .
EC with GAS bacteremia. At 48 h after EC, animals were given 8.2 ϫ 10 5 -1.3 ϫ 10 7 cfu/50 L washed, log-phase GAS strain 88-003 intravenously via the lateral tail vein. At 6 -8 h after GAS infusion, heparinized blood samples were obtained by retroorbital puncture, and spleens as well as TA and EDL muscles from both exercised and nonexercised legs were harvested and weighed. Preliminary experiments demonstrated this to be an optimal time for recovery of GAS from muscles. Muscles and spleens were homogenized using a mortar and pestle (Kontes) in 300 L of ice-cold sterile normal saline, and samples (50 L) were plated in duplicate on sheep blood agar plates. Colonies were counted the following day. Data are expressed as the number of colony-forming units per milligram (wet weight) of tissue, with a minimum level of detection of 3 cfu/muscle. EC, NSAIDs, and GAS bacteremia. At 47 h after EC, animals (n ϭ 16) were treated with either ketorolac tromethamine (Toradol; Hospira; 7.5 mg/kg in 0.5 mL intraperitoneally) or an equal volume of sterile saline. One hour later, animals were given GAS (3.6 ϫ 10 6 cfu/50 L) via the tail vein, and tissues were harvested 6 h after bacterial infusion.
RESULTS
Vimentin gene expression in mouse skeletal muscle after EC. Up-regulation of vimentin is a marker of skeletal muscle injury because healthy mature skeletal muscles do not express vimentin [11] [12] [13] [14] . Vimentin gene expression was followed over time by rtRT-PCR in hind-limb muscles from EC-and isometrically exercised animals and compared with that in the nonexercised, contralateral control muscles. In the EC-exercised TA muscles, vimentin gene expression was increased 2-4-fold at 12 h, was maximal at 48 h (mean, 7.8-fold; range, 2.8 -19.2-fold; P Ͻ .05 for the comparison with the control, by Duncan's test), and began to decline by 72 h (figure 1). The EC-induced increase in vimentin expression at 48 h was significantly greater than that at 12 or 24 h (figure 1) or than that measured 48 h after isometric exercise (mean, 3.1-fold; range, 1.4 -5.0-fold).
Sufficient total RNA for rtRT-PCR was not obtained from individual EDL muscles. Thus, total RNA was prepared from pooled EDL homogenates from 4 animals whose injured TA muscles demonstrated a mean 6.1-fold increase in vimentin gene expression compared with the nonexercised control TA muscles at 24 h after EC. There was no difference in vimentin gene expression between exercised and nonexercised EDL muscles (data not shown).
The change in the MIT from before to after exercise was used as a surrogate for vimentin expression to assess muscle injury in real time. EC exercise reduced the MIT by 11%-83% (mean Ϯ SD, 43.9% Ϯ 19.8%). In contrast, isometric exercise reduced this value by 0%-36% (mean Ϯ SD, 22.8% Ϯ 11.2%). The ECinduced reduction in MIT and the temporal dynamics of vimentin gene expression in the present study are comparable to those obtained elsewhere in a rat model of EC-induced muscle injury [10] . The decrease in MIT after isometric exercise was attributed to fatigue, given the short duration of rest (30 s) between the periods of exercise [10] . This conclusion is supported by the low level of vimentin gene expression after isometric exercise, a find- Figure 1 . Up-regulation of vimentin gene expression due to muscle injury. Mice (n ϭ 35) underwent eccentric contraction (EC) exercise, as described in Methods. Shown is the fold increase in vimentin expression in tibialis anterior muscles from the EC-exercised leg over the nonexercised leg. The mean isometric torque immediately after EC was reduced by 11%-83% in these animals (mean Ϯ SD, 43.9% Ϯ 19.8%) and did not differ between animals for the different time periods. Vimentin expression at 48 h was significantly greater than at 12 or 24 h. *P Ͻ .05, Duncan's test.
ing that is also consistent with other reports [15] . Thus, EC exercise caused definitive muscle injury as indicated by vimentin up-regulation. Because vimentin expression was maximal 48 h after EC, this time point was chosen for the administration of GAS in subsequent experiments.
Homing of GAS to the site of muscle injury. We hypothesized that circulating GAS from transient bacteremia would localize to the site of muscle injury. To test this, organisms were delivered intravenously to animals 48 h after EC-induced muscle injury, and, 6 h later, blood, spleen, and muscles were harvested for quantitative bacteriology. Variation between animals was observed in the absolute numbers of GAS in the blood and spleen. These differences were attributed to differences in animal size, individual variation in the ability to clear the organism, and differences in the sizes of the inocula used on different days. Furthermore, the design of these experiments (i.e., the killing of animals at a predetermined time) did not allow us to follow the distribution of GAS longitudinally in a single animal or to compare courses between individual animals.
Because of the variability in the intensity of muscle injury (as measured by the reduction in MIT), animals were divided into 2 groups on the basis of a median split: "minimal injury" versus "moderate injury" (reduction in MIT of 44% and Ͼ44%, respectively). Irrespective of the injury category, streptococci were rarely detected in the EDL, probably because the EC exercise protocol used does not create injury in the highly elastic EDL [10] . This conclusion is supported by our observation that no increase in vimentin gene expression was found in exercised EDL muscles in this model. In contrast, GAS were consistently found in the TA muscles. However, because of the nonnormality of the measures of GAS in the these muscles, a Wilcoxon signed rank test was chosen to evaluate statistical differences between the number of GAS in EC-injured and noninjured TA muscles in these 2 injury groups. For the minimally injured group (n ϭ 8), there was not a significant difference (S ϭ Ϫ3.5; P ϭ .73) in the number of GAS between injured and noninjured muscles (figure 2). In those sustaining moderate injury (n ϭ 8), injured muscles contained significantly more GAS than did the contralateral uninjured muscles (S ϭ 17.5; P ϭ .039) (figure 2). Examination of the means showed a 2-fold increase in organisms in the injured muscles compared with noninjured muscles. When the median was used as a measure of central tendency appropriate for nonnormal sample distributions, the same 2-fold increase was observed. This difference did not correlate with the number of circulating GAS at the time of muscle harvest, nor was it attributable to differences in the weights of the TA muscles. In total, these results support the notion that vimentin upregulation in injured muscles is associated with localization of GAS to the injured site.
Effects of NSAIDs on GAS infection of injured muscle. To determine the effects of NSAIDs on GAS infection of injured muscles, animals were given either ketorolac tromethamine or saline 47 h after EC and 1 h before GAS infusion. TA muscles were harvested 6 h later for bacterial quantitation. One animal in the NSAID-treated group had obvious anatomical abnormalities on dissection and was excluded from analysis. Two animals in the NSAID-treated group fell into the minimally injured category (reduction in MIT of Ͻ44%). This number did not allow Figure 2 . Increased binding of group A streptococci (GAS) in vivo due to moderate muscle injury. Mice (n ϭ 16) were exercised as described in Methods. GAS data are expressed as colony-forming units per milligram (wet weight) of tissue (mean Ϯ SE) in animals with minimal vs. moderate eccentric contraction (EC) injury of the tibialis anterior (TA) muscles (reduction in mean isometric torque 44% and Ͼ44%, respectively; n ϭ 8 per group) and noninjured (control) TA muscles. *P Ͻ .05, Wilcoxon signed rank test.
for meaningful statistical comparison between NSAID-treated and non-NSAID-treated animals in this injury category. However, 1 of 2 NSAID-treated animals had a 22-fold increase in the number of GAS in the EC-injured muscle compared with the noninjured control leg (data not shown).
Moderate muscle injury (reduction in MIT of Ͼ44%) caused an ϳ2-fold increase in the number of GAS in the TA muscle in non-NSAID-treated animals (figure 3). In stark contrast, administration of NSAIDs 1 h before infusion of GAS significantly increased the number of GAS in the injured TA muscle over that resulting from injury alone (figure 3). NSAID treatment also reduced the number of GAS in the noninjured muscle (figure 3), although this difference was not statistically significant.
DISCUSSION
A critical role for antecedent skeletal muscle injury has been well established for some bacterial infections, such as clostridial myonecrosis, in which a deep, penetrating injury directly introduces organisms (or spores) into devitalized tissues. Although the rate at which GAS myonecrosis progresses is comparable to that of clostridial gas gangrene (inches per hour), the antecedent injuries predisposing to GAS infection are distinctly different. In the no-portal group of patients with streptococcal myonecrosis, a minor muscle strain, sprain, or bruise is the rule [2, 3] . In fact, several authors have concluded that nonpenetrating muscle injury may be a prerequisite for GAS necrotizing fasciitis or myonecrosis [3, 4] . This implies that there is a subtle but specific interaction between GAS and skeletal muscle that initiates invasive GAS infection at the site of minor muscle injury.
Clinical findings and laboratory evidence support this notion. First, the temporal dynamics of vimentin expression after EC injury parallels the time course for development of infection in the no-portal human GAS myonecrosis cases-most patients present to emergency departments 24 -72 h after muscle injury because of increasing focal pain at the site of injury [1] . Second, large numbers of GAS adhere specifically to the surfaces of myofibrillar bundles in experimental animals with GAS myonecrosis [16] . Similar findings have been reported in fatal human cases of GAS myonecrosis [3, 8] . Third, using cultured human skeletal muscle cells, we have shown that adherence of GAS to injured cells was increased 2-5-fold over that in normal, healthy cells [8] . Fourth, we have identified vimentin as the major skeletal muscle surface protein that binds both M type 1 and 3 GAS [8] .
Results from the present study confirm that skeletal muscles do not express vimentin except during regeneration after injury [11] [12] [13] [14] and demonstrate that injured muscle tissues harbor more GAS than noninjured control muscles. Taken together, these data suggest that injury-induced up-regulation of vimentin facilitates the development of GAS myonecrosis at sites of muscle injury.
A role for NSAIDs in the development of severe streptococcal infection has long been proposed, yet controversy remains. For example, in one study, 92% of patients with StrepTSS reported antecedent NSAID use [17] . Similarly, in a case-control study of children with varicella, 42% of patients who developed lifethreatening GAS necrotizing fasciitis had received NSAIDs, compared with only 15% of patients who developed other, nonnecrotizing soft-tissue infections [18] . Another prospective study in children with primary varicella demonstrated only a slightly increased risk of GAS infection in those receiving both acetaminophen and ibuprofen compared with controls [19] , causing the authors to doubt the association between NSAIDs and GAS infection. A recent prospective epidemiologic study in the United Kingdom found that use of NSAIDs was independently associated with increased risk for StrepTSS [20] .
Despite this protracted controversy, until now no experimental studies have been undertaken to test the possible link between NSAIDs and GAS infection in general, and certainly none have specifically examined this relationship after muscle injury. The data presented here demonstrate for the first time that GAS travel from the bloodstream to sites of moderate muscle injury, likely via a vimentin-mediated process. Furthermore, NSAID administration at the time of peak vimentin expression markedly enhances GAS infection of injured muscles. Thus, 3 ingredients contribute to the development of severe, cryptic GAS Figure 3 . Augmentation of infection of injured skeletal muscles with group A streptococci (GAS) by nonsteroidal anti-inflammatory drugs (NSAIDs). Animals with moderate eccentric contraction (EC)-induced muscle injury (reduction in mean isometric torque, 63.8% Ϯ 11%) were treated with either ketorolac tromethamine (n ϭ 5) or saline (n ϭ 8) 1 h before intravenous administration of GAS. Six hours after bacterial challenge, muscles were harvested for quantitative bacteriology. Data are means Ϯ SEs. There was significant interaction (P Ͻ .001), as determined by 2-by-2 analysis of variance (ANOVA), with drug type (NSAID vs. no NSAID) as the between factor and muscle treatment (injury vs. no injury) as the within factor. *P Ͻ .001, post-hoc ANOVA.
muscle infections: vimentin-positive injured muscle, a source of GAS, and NSAIDs.
Inflammation, muscle regeneration, and vimentin expression are tightly linked processes (reviewed in [21] ). Immediately after injury, infiltrating neutrophils remove damaged muscle cells. As the neutrophil influx wanes, proinflammatory macrophages become dominant, secreting growth factors and prostaglandins that activate muscle cell precursors (satellite cells) to initiate de novo myofiber synthesis. Peak vimentin expression after injury is directly related to maximal proliferation of satellite cells [11] , which express vimentin both intracellularly and on their surface [8] . As fully mature adult muscle fibers are formed, vimentin expression declines [11, 12, 14] .
The mechanism whereby NSAIDs could facilitate severe GAS infections has not been studied, and some have concluded that NSAIDs simply confound early recognition of GAS infection and delay treatment [7] . However, blocking macrophage infiltration by NSAIDs or other means (e.g., experimental systemic depletion) significantly impedes muscle regeneration [22] [23] [24] . Delayed muscle cell maturation would prolong the availability of the GAS-binding target (vimentin) in the injured muscle. NSAIDs could also reduce the number of infiltrating phagocytes, leaving the invading organisms unchecked.
GAS bind to host tissue-specific proteins, such as fibronectin, collagen, and laminin (reviewed in [25] ), although evidence suggests that these proteins do not mediate the initial binding of GAS at sites of muscle injury. First, neither fibronectin, laminin, nor collagen was pulled down from cultured skeletal muscles by adherent M type 1 or 3 GAS [8] . Second, studies defining the distribution of the fibronectin-binding protein, protein F, among various M types indicated that M types 1 and 3 GAS (i.e., the 2 most common M types isolated from patients with invasive GAS infections) did not produce this protein [26] . Third, in our other experiments using the mouse model of EC, microarray analysis failed to demonstrate up-regulation of the genes for these proteins in injured TA muscles [10] . Fourth, in healthy humans, skeletal muscle collagen levels did not increase until 3 weeks after EC-induced muscle injury [27] . Last, EC-induced injury did not alter the organization of rat skeletal muscle laminin [28] . Thus, these proteins probably do not contribute to the interaction between GAS and skeletal muscle within the first 24 -48 h after injury. However, GAS ligands that could be exposed or increased at later stages of muscle injury and repair could augment initial vimentin-mediated binding and further the progression of infection.
In summary, we propose the following paradigm for the initiation of these enigmatic necrotizing GAS infections. By 24 -48 h after acute injury, regenerating myoblasts maximally express vimentin on their surface. In the absence of penetrating trauma, GAS traffic to the injured site, likely via a transient bacteremia from the oropharynx, and attach specifically to vimentin expressed on injured muscles in sufficient numbers to initiate infection. NSAID-induced delays in muscle regeneration and cellular immunosuppression further enhance GAS binding and facilitate unrestrained bacterial proliferation. Once established, proliferating organisms release potent cytolysins, causing further muscle cell injury and enabling intracellular vimentin to amplify the interaction between GAS and muscle.
Translational studies are currently ongoing to identify and block the GAS adhesin that binds to vimentin and to prevent GAS binding in vivo by directly silencing vimentin gene expression in injured muscle. Future studies will explore the roles played by the different cyclooxygenase isoforms in the interaction between GAS and injured muscle. Together, these studies may uncover novel therapeutic targets to prevent or attenuate this devastating infection. Until more is revealed about the role played by NSAIDs in this process, physicians should be alerted to possible deep-seated GAS infection in persons taking NSAIDs and presenting with increasing pain at the site of nonpenetrating muscle injury.
